ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOHAMMAD HUSSAIN M.D.

Internal Medicine

3,795

$157K

299
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$41
Average prescription price

Avg: $67

ADEBOLA OLATUNJI M.D.

Internal Medicine

19,898

$1.11M

498
294 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

SHAHRYAR NASSI MD

Internal Medicine

1,060

$79.8K

181
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

53%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

KALU OGBONNAYA M.D., P.A.

Internal Medicine

9,473

$655K

413
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

DHARSHINI WALLOOPPILLAI M.D.

Internal Medicine

6,778

$386K

111
109 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

35%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

GURNAIB SIDHU M.D.

Internal Medicine

5,524

$311K

357
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

GEORGE KATEI M.D.

Internal Medicine

9,865

$670K

284
154 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

MICHAEL MCPHERSON MD

Internal Medicine

301

$3,592

213
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

46%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

4%
prescriptions for brand name drugs

Avg: 27%

$12
Average prescription price

Avg: $67

JAMAL LONE M.D.

Internal Medicine

713

$35.1K

219
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

EDWARD MAZIQUE M.D.

Internal Medicine

6,578

$298K

289
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $67

MOURAD MANSOUR MD

Internal Medicine

2,665

$103K

142
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

49%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 27%

$39
Average prescription price

Avg: $67

JAIRAJ PATIL MD

Internal Medicine

4,027

$299K

136
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

46%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

SREEDHAR POLAVARAPU M.D.

Internal Medicine

4,057

$228K

127
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

YU LAN JANKOWSKI MD

Internal Medicine

850

$42.3K

57
24 are 65+

35%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

TERESA LYSON M.D.

Internal Medicine

792

$39.8K

154
126 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

PHONG LUU MD

Internal Medicine

4,594

$340K

363
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

TIMOTHY ALLEN DO

Internal Medicine

897

$33.3K

174
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$37
Average prescription price

Avg: $67

KOLAWOLE ODULAJA MD

Internal Medicine

765

$17.8K

268
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

46%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 27%

$23
Average prescription price

Avg: $67

SAMUEL NGWU MD

Internal Medicine

8,814

$583K

346
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

JOSEPH BURKS M D

Internal Medicine

2,853

$190K

182
63 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

46%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

NEIL ADELMAN MD

Internal Medicine

9,175

$510K

670
418 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

KELLY FELPS MD

Internal Medicine

13,045

$1.5M

519
299 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$115
Average prescription price

Avg: $67

JOSEPH KING MD

Internal Medicine

12,156

$792K

217
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

39%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

SHARON LARKIN M.D.

Internal Medicine

4,220

$253K

132
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

RONALD WONG M.D.

Internal Medicine

9,004

$506K

433
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank